Showing 1431-1440 of 2527 results for "".
- Galderma Donates 1,200 Backpacks Filled with School Supplies to Northwest ISD Studentshttps://modernaesthetics.com/news/galderma-donates-1200-backpacks-filled-with-school-supplies-to-northwest-isd-students/2472977/For the fifth consecutive year, Galderma donated backpacks filled with school supplies to Northwest Independent School District (NISD) students. This year, Galderma donated 1,200 backpacks for students in grades Kindergarten through 12, for a total of 6,105 backpacks donated since 2016.
- BTL Files New Complaint Against Allergan, Affiliates in Patent Fighthttps://modernaesthetics.com/news/btl-files-new-complaint-against-allergan-affiliates-in-patent-fight/2472976/BTL Industries, Inc. has filed a complaint with the United States International Trade Commission (ITC), asking the Commission to prevent Allergan Limited, Allergan, Inc., Allergan USA Inc., Zeltiq Aesthetics, Inc., Zeltiq Ireland Unlimited Company, and Zimmer MedizinSysteme GmbH, G
- New Leadership Roles at Dominion Aesthetic Technologieshttps://modernaesthetics.com/news/new-leadership-roles-at-dominion-aesthetic-technologies/2472975/Cooper Collins will lead
- Amber Edwards Named Alastin Skincare’s New Chief Commercial Officerhttps://modernaesthetics.com/news/amber-edwards-named-alastin-skincares-new-chief-commercial-officer/2472971/Amber Edwards is Alastin Skincare’s new Chief Commercial Officer, effective July 31, 2020 Ms. Edwards most recently served as President of North America for Sinclair Pharma. Prior to Sinclair, she was at Allergan, Inc. where she was the Vice President of International S
- Alastin Skincare Scores Another New Patenthttps://modernaesthetics.com/news/alastin-skincare-scores-another-new-patent/2472970/Alastin Skincare, Inc. received a fourth U.S. Patent from the United States Patent and Trademark Office. The new patent, which incorporates TriHex Technology, is directed to a topical composition for alleviating bruising caused by a cosmetic procedure—INhance Post-Injection Serum
- New from Cutera: Get to Know Fraxis PROhttps://modernaesthetics.com/news/new-from-cutera-get-to-know-fraxis-pro/2472965/Cutera, Inc. is launching Fraxis PRO progressive dermal remodeling technology. Fraxis PRO combines fractional CO2 for skin resurfacing and radiofrequency microneedling for dermal remodeling in a single device. Fraxis PRO treats: Fine Lines Wr
- Endo’s Qwo Scores FDA Nod for Cellulite Treatmenthttps://modernaesthetics.com/news/endos-qwo-scores-fda-nod-for-cellulite-treatment/2472961/The FDA has given its nod to an entirely new way to address cellulite. Endo Aesthetic’s Qwo (collagenase clostridium histolyticum-aaes) is the first injectable treatment for moderate to severe cellulite of the buttocks in adult women. When fat in cellulite-prone areas swells and e
- New Survey on Reopening after COVID-19: If You Wear Masks, They Will Come Backhttps://modernaesthetics.com/news/new-survey-on-reopening-after-covid-19-if-you-wear-masks-they-will-come-back/2472957/Fully 85 percent of people plan to return to aesthetic treatments within 12 months of COVID-19 restrictions being lifted, and 63 percent plan to return to practices within just three months of restrictions being lifted in their respective countries, according to a
- DocClocker App Now Features Remote Check-In to Prevent Spread of COVID-19 in Medical Practiceshttps://modernaesthetics.com/news/docclocker-app-now-features-remote-check-in-to-prevent-spread-of-covid-19-in-medical-practices/2472956/DocClocker, an app that allows patients to receive real-time wait time reporting of their medical providers, enabling patients to avoid long waits in medical waiting rooms and limit COVID-19 exposure risks, now offers DocClocker Remote Check-In. As practices reopen amid the COVID-19 pan
- Candela’s CO2RE Laser Platform Scores Health Canada Approval for Two New Gynecological Indicationshttps://modernaesthetics.com/news/candelas-co2re-laser-platform-scores-health-canada-approval-for-two-new-gynecological-indications/2472955/Health Canada has approved Candela’s CO2RE laser for the treatment of genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) in adult women. The CO2RE laser, a sing